Mid-Day Report: Market Focus Is Divided Between Fed & Q1 Earnings

The major indexes started the day with a bang but have given ground as the mood remains tentative given the Fed meeting and Apple's earnings due later today More 

Eli Lilly and Co (LLY) Stock Drops on Q1 Earnings

Eli Lilly stock was down on Tuesday after it released its Q1 earnings report with EPS that didn't match up to Wall Street's expectations. More 

Trade of the Day: Halozyme Therapeutics, Inc. (NASDAQ:HALO)

he current market cap for Halozyme Therapeutics (HALO) is at $1.5 billion, which makes it ripe as a takeover target. More 

3 Big Pharma Stocks to Buy, 3 to Avoid

Big Pharma stocks are under pressure as regulation threatens to curb drug prices and tax driven mergers are intercepted by the treasury. More 

7 Healthcare Stocks to Buy for Your Retirement

Longer term, healthcare stocks are where it's at. Here's seven of the best stocks to buy for the long haul. More 

These 54 Big Blue Chips Are On the Move

During these busy times it pays to stay on top of the latest blue chip opportunities. Today's blog post is a great place to start with these updated ratings More 

Eli Lilly and Co: Can LLY Stock Get Healthy Again?

Eli Lilly has been awful for investors this year, but LLY does have a robust pipeline that is focused on major diseases. More